" /> Generalized epilepsy with febrile seizures plus, type 2 - CISMeF





Preferred Label : Generalized epilepsy with febrile seizures plus, type 2;

Symbol : GEFSP2;

CISMeF acronym : FEB3A; GEFSP2; GEFS 2;

Type : Phenotype, molecular basis known;

Alternative titles and symbols : Gefs , type 2; GEFS 2;

Included titles and symbols : Febrile seizures, familial, 3a; FEB3A;

Description : Mutations in the SCN1A gene cause a spectrum of seizure disorders, ranging from early-onset isolated febrile seizures to generalized epilepsy with febrile seizures plus, type 2, which represents a more severe phenotype. Patients with isolated febrile seizures usually have onset between ages 6 months and 4 years and show spontaneous remission by age 6 years (summary by Mantegazza et al., 2005), whereas patients with GEFS continue to have various types of febrile and afebrile seizures later in life (summary by Singh et al., 2009). Dravet syndrome (607208), or severe myoclonic epilepsy of infancy, is the most severe phenotype associated with SCN1A mutations. Mutations in certain genes can cause a phenotypic spectrum of overlap between the isolated febrile phenotype and the GEFS phenotype. For a general phenotypic description and a discussion of genetic heterogeneity of GEFS , see 604233. For a phenotypic description and a discussion of genetic heterogeneity of familial febrile seizures, see 121210.;

Inheritance : Autosomal dominant;

Molecular basis : Caused by mutation in the voltage-gated sodium channel type I, alpha polypeptide gene (SCN1A, 182389.0001);

Prefixed ID : #604403;

Details


You can consult :


Nous contacter.
03/05/2025


[Home] [Top]

© Rouen University Hospital. Any partial or total use of this material must mention the source.